CanAg
Cantuzumab is a monoclonal antibody designed for the treatment of cancers. Also known as huC242 it binds the CanAg antigen.[1]
It is typically linked to one of several cytotoxic agents, yielding antibody-drug conjugates :
Cantuzumab is a monoclonal antibody designed for the treatment of cancers. Also known as huC242 it binds the CanAg antigen.[1]
It is typically linked to one of several cytotoxic agents, yielding antibody-drug conjugates :
This article uses material from the Wikipedia article CanAg, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.